Risk assessment in fever and neutropenia in children with cancer: What did we learn?

Esther M. te Poele, Wim J.E. Tissing, Willem A. Kamps, Eveline S.J.M. de Bont

Research output: Contribution to journalReview articlepeer-review

31 Citations (Scopus)

Abstract

Children with cancer treated with chemotherapy are susceptible to bacterial infections and serious infectious complications. However, fever and neutropenia can also result from other causes, for which no antibiotic treatment is needed. In the past decades attempts have been made to stratify the heterogeneous group of pediatric cancer patients with fever and neutropenia into high- and low-risk groups for bacterial infections or infectious complications. Strategies for risk assessment have resulted in treatment regimens with early discharge or even no hospital admission at all, and/or treatment with oral or no antibiotics. We will provide a historical overview of the changing approach to low-risk fever and neutropenia, and we will also try to identify clear and objective parameters for risk assessment strategies and illustrate their relationship to innate immunity. In the future, new insights into genetic susceptibility on neutropenic fever might be of use in children with cancer with fever and neutropenia.

Original languageEnglish
Pages (from-to)45-55
Number of pages11
JournalCritical Reviews in Oncology/Hematology
Volume72
Issue number1
DOIs
Publication statusPublished - Oct 2009
Externally publishedYes

Keywords

  • Antibiotics
  • Assessment
  • Cancer
  • Child
  • Fever
  • Neutropenia

Fingerprint

Dive into the research topics of 'Risk assessment in fever and neutropenia in children with cancer: What did we learn?'. Together they form a unique fingerprint.

Cite this